Stock BIO.B BIO-RAD LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Market Closed - Nyse
Other stock markets
 21:15:00 10/05/2024 BST 		5-day change 1st Jan Change
279.9 USD 0.00% Intraday chart for Bio-Rad Laboratories, Inc. 0.00% -12.71%
05-08 UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating MT
05-08 RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 MT

Chart calendar Bio-Rad Laboratories, Inc.

d6.4Z5dCLSgSJSlSH904jSBYeIq0yTFiV_d8jq6VV4Yt2E.ttQuPdjuMt_MeDQwhnHjDINTl0qo4hmukUrDFgdN2lmI8Gxm2c8YoNAFTw~e1362f97c77e75a4348144c74c77042d

Upcoming events on Bio-Rad Laboratories, Inc.

14/05/2024 19:05 RBC Capital Markets Global Healthcare Conference
24/07/2024 Q2 2024 Earnings Release (Projected)
23/10/2024 Q3 2024 Earnings Release (Projected)
12/02/2025 Q4 2024 Earnings Release (Projected)
23/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Bio-Rad Laboratories, Inc.

07/05/2024 22:00 Q1 2024 Earnings Call
07/05/2024 21:15 Q1 2024 Earnings Release
24/04/2024 00:00 Annual General Meeting
29/02/2024 19:30 Citi Unplugged Medtech and Life Sciences Access Day
15/02/2024 22:00 Q4 2023 Earnings Call
15/02/2024 21:15 Q4 2023 Earnings Release
07/01/2024 JPMorgan Healthcare Conference
26/10/2023 22:00 Q3 2023 Earnings Call
26/10/2023 21:15 Q3 2023 Earnings Release
07/09/2023 16:00 Wells Fargo Healthcare Conference
03/08/2023 22:00 Q2 2023 Earnings Call
03/08/2023 21:15 Q2 2023 Earnings Release
08/06/2023 20:00 Jefferies Global Healthcare Conference
17/05/2023 20:35 RBC Global Healthcare Conference
04/05/2023 22:00 Q1 2023 Earnings Call
04/05/2023 21:15 Q1 2023 Earnings Release
26/04/2023 00:00 Annual General Meeting
02/03/2023 16:45 Citi Healthcare Services Medtech Tools & HCIT Conference
16/02/2023 22:00 FY 2022 Earnings Call
16/02/2023 21:05 FY 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		2 312
2 329
-0.73%		2 546
2 430
4.76%		2 923
2 893
1.04%		2 802
2 816
-0.49%		2 671
2 676
-0.18%
2 661

EBITDA
Million USD		Released
Forecast
Spread 		390
406
-4.12%		537
522
2.96%		677
678
-0.04%		668
635
5.14%		536
521
2.92%
470

EBIT
Million USD		Released
Forecast
Spread 		279
294
-5.39%		427
403
5.8%		571
598
-4.49%		524
530
-1.09%		379
383
-1.13%
347

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		4 908
3 985
23.15%		5 438
694
683.59%		0,00
0,00
- 		-850
503
-269.07%
377

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		3 806
3 087
23.3%		4 246
541
684.82%		-3 628
-3 508
-3.42%		-637
392
-262.67%
294

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		126
102
23.37%		141
17,9
683.94%		0,00
0,00
- 		-21,8
13,5
-262.11%
10,3

Announcement Date13/02/2011/02/2110/02/2216/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		733
732
0.11%		700
677
3.48%		691
674
2.6%		681
683
-0.28%		730
741
-1.45%		677
689
-1.8%		681
696
-2.12%		632
692
-8.61%		681
687
-0.79%		611
620
-1.5%
641


669


733


649

EBITDA
Million USD		Released
Forecast
Spread 		140
140
0.06%		179
138
30.25%		156
135
16.12%		132
140
-5.26%		156
167
-6.51%		149
151
-1.79%		138
134
2.51%		113
143
-21.03%		137
136
0.61%		109
91,3
18.86%
93,0


119


155


114

EBIT
Million USD		Released
Forecast
Spread 		113
108
4.14%		154
109
41.6%		130
106
23.09%		106
111
-4.46%		127
140
-9.16%		84,2
122
-31.13%		108
106
2.07%		81,6
112
-27.14%		105
107
-1.39%		59,0
61,8
-4.48%
64,9


88,8


122


82,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread

















-1 500
108
-1491.07%




















Net income
Million USD		Released
Forecast
Spread











828
953
-13.17%


-1 162
83,6
-1490.39%


350

















EPS
USD		Released
Forecast
Spread








-5,52
2,63
-309.89%





-39,6
2,81
-1508.9%




















Announcement Date10/02/2228/04/2228/07/2227/10/2216/02/2304/05/2303/08/2326/10/2315/02/2407/05/24----

Upcoming sector events for Bio-Rad Laboratories, Inc.

12/05/2024 PARAMOUNT BED HOLDINGS CO., LTD.: Q4 2023 Earnings Release
13/05/2024 HLB CO., LTD.: Q1 2024 Earnings Release (Projected)
13/05/2024 TERUMO CORPORATION: Q4 2023 Earnings Release
13/05/2024 ALFRESA HOLDINGS CORPORATION: Q4 2023 Earnings Release
14/05/2024 06:00 AMBU A/S: Q2 2024 Earnings Release
14/05/2024 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 HOYA CORPORATION: Q4 2023 Earnings Release
16/05/2024 07:00 CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update
22/05/2024 06:00 YPSOMED HOLDING AG: Q4 2024 Earnings Release
23/05/2024 11:45 MEDTRONIC PLC: Q4 2024 Earnings Release
More events

Past sector events for Bio-Rad Laboratories, Inc.

10/05/2024 21:10 ATRION CORPORATION: Q1 2024 Earnings Release
09/05/2024 NIPRO CORPORATION: Q4 2023 Earnings Release
09/05/2024 PHC HOLDINGS CORPORATION: Q4 2023 Earnings Release
09/05/2024 21:30 METTLER-TOLEDO INTERNATIONAL, INC.: Q1 2024 Earnings Release
09/05/2024 21:03 BIOLIFE SOLUTIONS, INC.: Q1 2024 Earnings Release
09/05/2024 21:01 INSULET CORPORATION: Q1 2024 Earnings Release
09/05/2024 11:30 STEVANATO GROUP S.P.A.: Q1 2024 Earnings Release
09/05/2024 11:30 EMBECTA CORP.: Q2 2024 Earnings Release
09/05/2024 11:00 HAEMONETICS CORPORATION: Q4 2024 Earnings Release
08/05/2024 POLY MEDICURE LIMITED: Q4 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIO Stock
  4. BIO.B Stock
  5. Calendar Bio-Rad Laboratories, Inc.